CD40L-adjuvanted DNA vaccine carrying EBV-LMP2 antigen enhances anti-tumor effect in NPC transplantation tumor animal.

Lei, Lei; Li, Jianhui; Liu, Meiqing; Hu, Xiaoming; Zhou, Ya; Yang, Shiming

Lei, Lei; Li, Jianhui; Liu, Meiqing; Hu, Xiaoming; Zhou, Ya; Yang, Shiming.

Afiliação

Lei L; Department of Otolaryngology, Head and Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, China.
Li J; Department of Otolaryngology, Head and Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, China.
Liu M; School of Optoelectronics, Beijing Institute of Technology, Beijing, China.
Hu X; School of Optoelectronics, Beijing Institute of Technology, Beijing, China.
Zhou Y; School of Optoelectronics, Beijing Institute of Technology, Beijing, China.
Yang S; Department of Otolaryngology, Head and Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, China.

Cent Eur J Immunol ; 43(2): 117-122, 2018.

Article em En | MEDLINE | ID: mdl-30135622

Palavras-chave

CD40L; DNA vaccine; Epstein-Barr virus; anti-tumor; nasopharyngeal carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Cent Eur J Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google